Diva Laboratories (ROCO:4153) ROCE % : 12.74% (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Diva Laboratories ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Diva Laboratories's annualized ROCE % for the quarter that ended in Mar. 2024 was 12.74%.

Diva Laboratories ROCE % Historical Data

The historical data trend for Diva Laboratories's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diva Laboratories ROCE % Chart

Diva Laboratories Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

5.95

5.64

2.60

2.89

6.76

Diva Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
ROCE %	Get a 7-Day Free Trial															12.57	11.10	3.27	10.08	12.74

Diva Laboratories ROCE % Calculation

Diva Laboratories's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	67.844	/	( ( (1181.689 - 192.27)	+	(1251.798 - 234.591) )	/ 2 )
	=	67.844	/	( (989.419	+	1017.207)	/ 2 )
	=	67.844	/	1003.313
	=	6.76 %

Diva Laboratories's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Sep. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Sep. 2023 )		(Q: Mar. 2024 )
	=	127.784	/	( ( (1223.63 - 207.739)	+	(1293.692 - 303.362) )	/ 2 )
	=	127.784	/	( ( 1015.891	+	990.33 )	/ 2 )
	=	127.784	/	1003.1105
	=	12.74 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Diva Laboratories (ROCO:4153) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Diva Laboratories ROCE % Related Terms

Thank you for viewing the detailed overview of Diva Laboratories's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Diva Laboratories (ROCO:4153) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diva Laboratories Ltd (ROCO:4153) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

9F, No. 351 Sector 2, Chung Shan Road, Chung Ho, New Taipei City, TWN, 235

Website

http://www.diva.com.tw

Diva Laboratories Ltd is a Taiwan-based company that engages in the manufacturing and sale of a medical display. It offers endo/surgical displays; color displays for radiology and medical imaging services; touch displays; and original design manufacturing and original equipment manufacturing solutions.

Diva Laboratories (ROCO:4153) Headlines

No Headlines